Literature DB >> 22643830

Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection.

Tsuyoshi Umehara1, Kosuke Kato, Yong Sung Park, Erik P Lillehoj, Hideyuki Kawauchi, Kwang Chul Kim.   

Abstract

OBJECTIVE AND
DESIGN: To determine whether repetitive airway Pseudomonas aeruginosa (Pa) infection results in lung inflammation and injury and, if so, whether these responses are affected by Muc1 mucin. Muc1 wild type (WT) and knockout (KO) mice were compared for body weights, lung inflammatory responses, and airspace enlargement using a chronic lung infection model system. MATERIALS: Mice were treated intranasally with Pa (10(7) CFU) on days 0, 4, 7 and 10. On day 14, body weights, inflammatory cell numbers in bronchoalveolar lavage fluid (BALF), and airspace enlargement were measured. Differences in inflammatory responses between groups were statistically analyzed by the Student's t test and ANOVA.
RESULTS: Muc1 WT mice exhibited mild degrees of both inflammation and airspace enlargement following repetitive airway Pa infection. However, Muc1 KO mice exhibited significantly decreased body weights, greater macrophage numbers in the BALF, and increased airspace enlargement compared with Muc1 WT mice.
CONCLUSIONS: This is the first report demonstrating that Muc1 deficiency can lead to lung injury during chronic Pa infection in mice. These results suggest that MUC1 may play a crucial role in the resolution of inflammation during chronic respiratory infections and that MUC1 dysfunction likely contributes to the pathogenesis of chronic inflammatory respiratory disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22643830      PMCID: PMC3419284          DOI: 10.1007/s00011-012-0494-y

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  56 in total

1.  TNF-α is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection.

Authors:  Seongwon Choi; Yong Sung Park; Takeshi Koga; Allison Treloar; Kwang Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-06       Impact factor: 6.914

2.  Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice.

Authors:  A M van Heeckeren; J Tscheikuna; R W Walenga; M W Konstan; P B Davis; B Erokwu; M A Haxhiu; T W Ferkol
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

3.  KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts.

Authors:  Y Hirasawa; N Kohno; A Yokoyama; Y Inoue; M Abe; K Hiwada
Journal:  Am J Respir Cell Mol Biol       Date:  1997-10       Impact factor: 6.914

4.  Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema.

Authors:  T Betsuyaku; M Nishimura; K Takeyabu; M Tanino; P Venge; S Xu; Y Kawakami
Journal:  Am J Respir Crit Care Med       Date:  1999-06       Impact factor: 21.405

5.  Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.

Authors:  M Miravitlles; C Espinosa; E Fernández-Laso; J A Martos; J A Maldonado; M Gallego
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

6.  Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88.

Authors:  Kosuke Kato; Erik P Lillehoj; Yong Sung Park; Tsuyoshi Umehara; Nicholas E Hoffman; Muniswamy Madesh; K Chul Kim
Journal:  J Immunol       Date:  2012-01-16       Impact factor: 5.422

7.  Pseudomonas aeruginosa stimulates phosphorylation of the airway epithelial membrane glycoprotein Muc1 and activates MAP kinase.

Authors:  Erik P Lillehoj; Hakryul Kim; Ellen Y Chun; K Chul Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-06-25       Impact factor: 5.464

8.  A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia.

Authors:  J R Starke; M S Edwards; C Langston; C J Baker
Journal:  Pediatr Res       Date:  1987-12       Impact factor: 3.756

9.  Scanning electronmicroscopic morphometry of emphysema in humans.

Authors:  A Nagai; H Inano; K Matsuba; W M Thurlbeck
Journal:  Am J Respir Crit Care Med       Date:  1994-11       Impact factor: 21.405

Review 10.  MUC1, the renaissance molecule.

Authors:  S J Gendler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.698

View more
  19 in total

Review 1.  The Interaction between Respiratory Pathogens and Mucus.

Authors:  Mark Zanin; Pradyumna Baviskar; Robert Webster; Richard Webby
Journal:  Cell Host Microbe       Date:  2016-02-10       Impact factor: 21.023

Review 2.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

3.  Membrane-Tethered MUC1 Mucin Counter-Regulates the Phagocytic Activity of Macrophages.

Authors:  Kosuke Kato; Reina Uchino; Erik P Lillehoj; Kenneth Knox; Yong Lin; K Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

4.  Pseudomonas aeruginosa increases MUC1 expression in macrophages through the TLR4-p38 pathway.

Authors:  Kosuke Kato; Alec D Hanss; Marina A Zemskova; Nicole E Morgan; Marianne Kim; Kenneth S Knox; Yong Lin; Erik P Lillehoj; Kwang Chul Kim
Journal:  Biochem Biophys Res Commun       Date:  2017-08-16       Impact factor: 3.575

5.  MUC1 contributes to goblet cell metaplasia and MUC5AC expression in response to cigarette smoke in vivo.

Authors:  Kosuke Kato; Eugene H Chang; Yin Chen; Wenju Lu; Marianne M Kim; Maki Niihori; Louise Hecker; Kwang Chul Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-13       Impact factor: 5.464

6.  The cell surface mucin MUC1 limits the severity of influenza A virus infection.

Authors:  J L McAuley; L Corcilius; H-X Tan; R J Payne; M A McGuckin; L E Brown
Journal:  Mucosal Immunol       Date:  2017-03-22       Impact factor: 7.313

Review 7.  Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer.

Authors:  Jos P M van Putten; Karin Strijbis
Journal:  J Innate Immun       Date:  2017-01-05       Impact factor: 7.349

Review 8.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

9.  Pseudomonas aeruginosa stimulates tyrosine phosphorylation of and TLR5 association with the MUC1 cytoplasmic tail through EGFR activation.

Authors:  Kosuke Kato; Erik P Lillehoj; Kwang Chul Kim
Journal:  Inflamm Res       Date:  2015-12-08       Impact factor: 4.575

10.  MUC1 regulates epithelial inflammation and apoptosis by PolyI:C through inhibition of Toll/IL-1 receptor-domain-containing adapter-inducing IFN-β (TRIF) recruitment to Toll-like receptor 3.

Authors:  Kosuke Kato; Erik P Lillehoj; Kwang Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2014-09       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.